secwatch.observer — SEC 8-K summary
======================================

Issuer:     Larimar Therapeutics, Inc. (LRMR)
CIK:        0001374690
Form:       8-K
Filed at:   2025-01-27T23:59:59+00:00
Accession:  0000950170-25-009196
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Larimar grants performance-based PSUs to four top executives
------------------------------------------------------------

- CEO Carole Ben-Maimon receives 100,000 PSUs tied to regulatory milestones.
- CFO Michael Celano gets 50,000 PSUs; CDO Gopi Shankar and CMO Russell Clayton each get 25,000.
- PSUs vest 50% upon milestone achievement determination and 50% one year later.
- All grants made Jan 22, 2025 under the 2020 Equity Incentive Plan; forfeiture upon termination before vesting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1374690/000095017025009196/0000950170-25-009196-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1374690/000095017025009196/lrmr-20250122.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-009196

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer